IP Library Granted Patent US 7,947,655
Granted Patent B2
US 7,947,655 · App. 12/604,165 · Granted May 24, 2011

Methods for making proteins containing free cysteine residues

Assignee: Bolder Biotechnology, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,655
App. No.
12/604,165
Granted
May 24, 2011
Kind
B2
Abstract

The present invention relates to novel methods of making soluble proteins having free cysteines in which a host cell is exposed to a cysteine blocking agent. The soluble proteins produced by the methods can then be modified to increase their effectiveness. Such modifications include attaching a PEG moiety to form pegylated proteins.

Claims (4)

1. A recombinant PEGylated cysteine variant of human alpha interferon-2, wherein said PEGylated alpha interferon-2 comprises a polyethylene glycol attached to a cysteine residue that has been substituted for at least one amino acid selected from the group consisting of H7, V105, and M111, wherein said variant inhibits proliferation in vitro of a Daudi cell line whose proliferation is inhibited by alpha interferon.

2. The recombinant cysteine variant of claim 1 , wherein a cysteine residue is substituted for H7.

3. The recombinant cysteine variant of claim 1 , wherein a cysteine residue is substituted for V105.

4. The recombinant cysteine variant of claim 1 , wherein a cysteine residue is substituted for M111.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 3, 2014
From: BOLDER BIOTECHNOLOGY, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033889/0403 →
Continuity (4)
Continuation 10857644 · May 27, 2004
Division 09889273
Provisional Application 60116041 · Jan 14, 1999
Related Publication 20100048872A1 · Feb 25, 2010